Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cole Maguire

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Medrxiv : the Preprint Server for Health Sciences|March 17, 2025
Analysis of 977 Long COVID Patients Reveals Prevalent Neuropathy and Association with Anti-Ganglioside AntibodiesCole Maguire, Kristina Kashyap, Elizabeth Williams, et al.
Medrxiv : the Preprint Server for Health Sciences|December 18, 2023
SARS-CoV-2 Humoral Immune Responses in Convalescent Individuals Over 12 Months Reveal Severity-Dependent Antibody DynamicsNadia Siles, Maisey Schuler, Cole Maguire, et al.
Communications Medicine|May 2, 2025
SARS-CoV-2 humoral immune responses in convalescent individuals over 12 months reveal severity-dependent antibody dynamicsNadia Siles Alvarado, Maisey Schuler, Cole Maguire, et al.
Research Square|January 10, 2024
Host-Microbe Multi-omic Profiling Identifies a Unique Program of COVID-19 Inflammatory Dysregulation in Solid Organ Transplant RecipientsCharles Langelier, Harry Pickering, Joanna Schaenman, et al.
Nature Communications|January 10, 2025
Host-microbe multiomic profiling identifies distinct COVID-19 immune dysregulation in solid organ transplant recipientsHarry Pickering, Joanna Schaenman, Hoang Van Phan, et al.
The Journal of Clinical Investigation|May 1, 2024
Integrated longitudinal multiomics study identifies immune programs associated with acute COVID-19 severity and mortalityJeremy P Gygi, Cole Maguire, Ravi K Patel, et al.
Biorxiv : the Preprint Server for Biology|November 21, 2023
Integrated longitudinal multi-omics study identifies immune programs associated with COVID-19 severity and mortality in 1152 hospitalized participantsJeremy P Gygi, Cole Maguire, Ravi K Patel, et al.
Research Square|June 30, 2025
Empiric Azithromycin in COVID-19 Impacts the Respiratory Microbiome and Antimicrobial Resistome without Anti-inflammatory BenefitCharles Langelier, Abigail Glascock, Cole Maguire, et al.
Cell Reports. Medicine|June 16, 2023
Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patientsJoann Diray-Arce, Slim Fourati, Naresh Doni Jayavelu, et al.
Nature Microbiology|March 17, 2026
Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19Abigail Glascock, Cole Maguire, Hoang Van Phan, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Medrxiv : the Preprint Server for Health Sciences|March 17, 2025
Analysis of 977 Long COVID Patients Reveals Prevalent Neuropathy and Association with Anti-Ganglioside AntibodiesCole Maguire, Kristina Kashyap, Elizabeth Williams, et al.
Medrxiv : the Preprint Server for Health Sciences|December 18, 2023
SARS-CoV-2 Humoral Immune Responses in Convalescent Individuals Over 12 Months Reveal Severity-Dependent Antibody DynamicsNadia Siles, Maisey Schuler, Cole Maguire, et al.
Communications Medicine|May 2, 2025
SARS-CoV-2 humoral immune responses in convalescent individuals over 12 months reveal severity-dependent antibody dynamicsNadia Siles Alvarado, Maisey Schuler, Cole Maguire, et al.
Research Square|January 10, 2024
Host-Microbe Multi-omic Profiling Identifies a Unique Program of COVID-19 Inflammatory Dysregulation in Solid Organ Transplant RecipientsCharles Langelier, Harry Pickering, Joanna Schaenman, et al.
Nature Communications|January 10, 2025
Host-microbe multiomic profiling identifies distinct COVID-19 immune dysregulation in solid organ transplant recipientsHarry Pickering, Joanna Schaenman, Hoang Van Phan, et al.
The Journal of Clinical Investigation|May 1, 2024
Integrated longitudinal multiomics study identifies immune programs associated with acute COVID-19 severity and mortalityJeremy P Gygi, Cole Maguire, Ravi K Patel, et al.
Biorxiv : the Preprint Server for Biology|November 21, 2023
Integrated longitudinal multi-omics study identifies immune programs associated with COVID-19 severity and mortality in 1152 hospitalized participantsJeremy P Gygi, Cole Maguire, Ravi K Patel, et al.
Research Square|June 30, 2025
Empiric Azithromycin in COVID-19 Impacts the Respiratory Microbiome and Antimicrobial Resistome without Anti-inflammatory BenefitCharles Langelier, Abigail Glascock, Cole Maguire, et al.
Cell Reports. Medicine|June 16, 2023
Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patientsJoann Diray-Arce, Slim Fourati, Naresh Doni Jayavelu, et al.
Nature Microbiology|March 17, 2026
Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19Abigail Glascock, Cole Maguire, Hoang Van Phan, et al.
Pageof 3